Citation Impact
Citing Papers
11β-Hydroxysteroid Dehydrogenase
1997
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
2007 StandoutNobel
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
2005 Standout
Finasteride in the treatment of men with androgenetic alopecia
1998
The biological action of saponins in animal systems: a review
2002 Standout
Effect of Testosterone Replacement Therapy on Prostate Tissue in Men With Late-Onset Hypogonadism
2006
11β‐Hydroxysteroid dehydrogenase and enzyme‐mediated receptor protection: Life after liquorice?
1991
The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society
2003 Standout
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
2008 Standout
Harmless Herbs? A Review of the Recent Literature
1998 Standout
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
2003 StandoutNobel
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Low-Renin Hypertension of Childhood
2011
Molecular Mechanisms of Human Hypertension
2001 Standout
Cushing's syndrome
2015 Standout
Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism
1991 Nature
Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning
2002
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Short-chain dehydrogenases/reductases (SDR)
1995 Standout
Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials
1996
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Outcome measures for research in treatment of adult males with symptoms of lower urinary tract dysfunction
1998
Shear Wave Ultrasound Elastography of the Prostate
2012
Examination of Genotype and Phenotype Relationships in 14 Patients with Apparent Mineralocorticoid Excess1
1998
Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
2000
Salivary cortisol as a biomarker in stress research
2008 Standout
Genetic Susceptibility for Human Familial Essential Hypertension in a Region of Homology with Blood Pressure Linkage on Rat Chromosome 10
1997 StandoutNobel
Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)
2011
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial
1998
Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients
1996
Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.
1992
Type I Pseudohypoaldosteronism Includes Two Clinically and Genetically Distinct Entities with either Renal or Multiple Target Organ Defects
1991
Solifenacin Plus Tamsulosin Combination Treatment in Men With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction: A Randomized Controlled Trial
2012
The Influence of Finasteride on the Development of Prostate Cancer
2003 Standout
Mineralocorticoid hypertension
1999
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
An overview on 5α-reductase inhibitors
2009
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
2002
Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism
2000
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
ANDROGEN METABOLISM AS IT AFFECTS HAIR GROWTH IN ANDROGENETIC ALOPECIA
1996
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Importance of quantitative genetic variations in the etiology of hypertension
2000 StandoutNobel
Expression Cloning and Characterization of Oxidative 17β- and 3α-Hydroxysteroid Dehydrogenases from Rat and Human Prostate
1997
Multicomponent domino reactions for the synthesis of biologically active natural products and drugs
2000 Standout
Apparent mineralocorticoid excess
2001
Conformationally Controlled Electron Delocalization in n‐Type Rods: Synthesis, Structure, and Optical, Electrochemical, and Spectroelectrochemical Properties of Dicyanocyclophanes
2011 StandoutNobel
The Biology of Hair Follicles
1999 Standout
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1
1996
Anticancer steroids: linking natural and semi-synthetic compounds
2012
Licorice Inhibits Corticosteroid 1lβ-Dehydrogenase of Rat Kidney and Liver:In Vivoandin VitroStudies*
1989
A review of the clinical efficacy and safety of 5α-reductase inhibitors for the enlarged prostate
2007
Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
1995
Differential alterations in 5α‐reductase type 1 and type 2 levels during development and progression of prostate cancer
2004
The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization.
1991
Molecular Genetics of Human Blood Pressure Variation
1996 Science
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
1997
Christian Raetz: Scientist and Friend Extraordinaire
2013 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Preparation and biological activity of tricyclic non-steroidal inhibitors of human steroid 5α-reductase
1997
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study
2002
Marine natural products
2015 Standout
Cloning of Human Mineralocorticoid Receptor Complementary DNA: Structural and Functional Kinship with the Glucocorticoid Receptor
1987 StandoutScience
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Synthese enantiomerenreiner Heterosteroide durch intramolekulare Hetero‐Diels‐Alder‐Reaktion
1990
Aldosterone-Receptor Deficiency in Pseudohypoaldosteronism
1985
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Prevention of Hormone-Related Cancers: Prostate Cancer
2005
Domino Reactions in Organic Synthesis
2006 Standout
A Mouse View of Hypertension
1997 StandoutNobel
Direct measurement of auger recombination in In0.1Ga0.9N/GaN quantum wells and its impact on the efficiency of In0.1Ga0.9N/GaN multiple quantum well light emitting diodes
2009
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
Evidence for atrophy and apoptosis in the prostates of men given finasteride.
1996
Controls of Hair Follicle Cycling
2001 Standout
Gene Targeting Approaches to Analyzing Hypertension
1999 StandoutNobel
The Influence of Androgen Deprivation Therapy on Dihydrotestosterone Levels in the Prostatic Tissue of Patients with Prostate Cancer
2004
Finasteride for benign prostatic hyperplasia
2010
Is the Spontaneously Hypertensive Stroke Prone Rat a Pertinent Model of Sub Cortical Ischemic Stroke? A Systematic Review
2011
Determination of internal parameters for AlGaN-cladding-free m-plane InGaN/GaN laser diodes
2011 StandoutNobel
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
The reduction of efficiency droop by Al0.82In0.18N/GaN superlattice electron blocking layer in (0001) oriented GaN-based light emitting diodes
2012 StandoutNobel
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
2005
The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society
2002 Standout
Works of E Stoner being referenced
Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia
2002
Effect of finasteride on prostate-specific antigen density
1994
Hormonal effects of an orally active 4‐azasteroid inhibitor of 5α‐reductase in humans
1989
Prostate Volume and Serum Prostate–Specific Antigen as Predictors of Acute Urinary Retention
2000
Scandinavian Clinical Study of Finasteride in the Treatment of Benign Prostatic Hyperplasia
1992
NEW FINDINGS IN APPARENT MINERALOCORTICOID EXCESS
1987
Clinical results with finasteride.
1994
Maximum Urinary Flow Rate by Uroflowmetry: Automatic or Visual Interpretation
1993
Temperature-dependent measurement of Auger recombination in self-organized In0.4Ga0.6As/GaAs quantum dots
2001
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.
1992
Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group
1994
Apparent Mineralocorticoid Excess Causing Hypertension and Hypokalemia in Children
1986
Primary hyperaldosteronism in childhood due to unilateral macronodular hyperplasia. Case report.
1984
Pseudohypoaldosteronism: A Review and Report of Two New Cases
1986